Product Details for ANDA 074215
ALPRAZOLAM (ALPRAZOLAM)
0.25MG
Marketing Status: Discontinued
0.5MG
Marketing Status: Discontinued
1MG
Marketing Status: Discontinued
2MG
Marketing Status: Discontinued
0.25MG
Marketing Status: Discontinued
Active Ingredient: ALPRAZOLAM
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 001
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ALPRAZOLAM (ALPRAZOLAM)
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 001
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
0.5MG
Marketing Status: Discontinued
Active Ingredient: ALPRAZOLAM
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 002
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ALPRAZOLAM (ALPRAZOLAM)
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 002
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
1MG
Marketing Status: Discontinued
Active Ingredient: ALPRAZOLAM
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 003
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ALPRAZOLAM (ALPRAZOLAM)
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 003
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2MG
Marketing Status: Discontinued
Active Ingredient: ALPRAZOLAM
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 004
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ALPRAZOLAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074215
Product Number: 004
Approval Date: Jan 27, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information